News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
273 Results
Type
Article (35)
Press Release (238)
Section
Business (119)
Deals (15)
Drug Development (54)
FDA (3)
Job Trends (2)
News (166)
Policy (9)
Tag
Academia (1)
Alliances (9)
Approvals (3)
Autoimmune disease (2)
Best Places to Work (2)
Clinical research (50)
COVID-19 (4)
C-suite (1)
Data (7)
Diagnostics (1)
Earnings (79)
Events (42)
Executive appointments (1)
FDA (3)
Government (2)
Healthcare (7)
Immunology and inflammation (1)
Infectious disease (4)
IPO (9)
Layoffs (1)
Legal (3)
Medical device (1)
Medtech (1)
Mergers & acquisitions (7)
NextGen: Class of 2026 (1)
People (41)
Phase 1 (17)
Phase 2 (30)
Phase 3 (20)
Pipeline (9)
Preclinical (2)
Real estate (2)
Regulatory (5)
Research institute (1)
Startups (8)
Date
Last 30 days (2)
Last 365 days (28)
2026 (3)
2025 (27)
2024 (25)
2023 (33)
2022 (35)
2021 (30)
2020 (31)
2019 (27)
2018 (17)
2016 (2)
2015 (1)
2014 (1)
2013 (14)
2012 (27)
Location
Asia (27)
California (4)
Europe (53)
Florida (1)
Maryland (2)
Massachusetts (1)
Minnesota (1)
Nevada (1)
New York (28)
North Carolina (1)
Northern California (3)
Pennsylvania (1)
United States (38)
273 Results for "immunovant".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immunovant Announces Pricing of $550 Million Common Stock Financing
December 11, 2025
·
4 min read
Press Releases
Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
January 26, 2026
·
1 min read
Press Releases
Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025
November 10, 2025
·
12 min read
Autoimmune disease
Immunovant Will Drop One Myasthenia Gravis Asset, Continuing to Favor Another
Analysts were happy with batoclimab’s performance in the chronic autoimmune disorder, but Immunovant said it will continue to focus on another next-gen asset for the indication.
March 19, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
October 28, 2025
·
1 min read
Press Releases
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025
August 12, 2025
·
10 min read
Press Releases
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves’ Disease Patients
September 4, 2025
·
7 min read
Press Releases
Immunovant Announces $450 Million Private Placement
January 14, 2025
·
3 min read
Press Releases
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025
May 29, 2025
·
11 min read
Press Releases
Immunovant Reports Financial Results for the Quarter Ended December 31, 2024
February 6, 2025
·
11 min read
1 of 28
Next
